








Campylobacter spp. are a common cause of foodborne outbreaks 
associated with raw or unpasteurized milk, and Campylobacter spp. have also 
been detected on most dairies in the US. An estimate of the prevalence of 
thermophilic Campylobacter spp. in bulk tank milk (BTM) on US dairy 
operations was determined as part of the National Animal Health Monitoring 
System’s Dairy 2014 study. Campylobacter spp. were detected in the BTM and 
milk filters from 34.2% of the 234 dairies. Isolates were obtained from 18.4% of 
the dairies. C. jejuni was the most frequently isolated species, and this species is 
also the most common cause of human infection. When resistance to a panel of 
nine antimicrobials was tested, 68.4% of C. jejuni isolates were resistant to 
tetracycline. This survey suggests that BTM from US dairies can be contaminated 
with pathogenic Campylobacter spp., and the consumption of unpasteurized, raw 
milk represents a human health risk. 
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Chapter 1: Introduction 
Campylobacter spp. are small, spiral and motile gram-negative bacteria 
that are approximately 0.2 to 0.8 µm wide and 0.5 to 5 µm long and reside in the 
gastrointestinal tract of many warm-blooded animals (Debruyne et al., 2008). 
There are currently between 16 and 20 recognized Campylobacter species as well 
as multiple subspecies and biovars. Campylobacter was first described by 
Theodor Escherich in 1886 and was later identified in sheep in 1906 and in 
aborted bovine fetuses in 1913 (Debruyne et al., 2008). Following improvements 
in culture techniques, Campylobacter spp. were also recognized as a human 
pathogen in the late twentieth century. Campylobacter spp. are now a leading 
bacterial cause of human gastrointestinal illness in both the developing and 
developed world. In the US, Campylobacter spp. infections have increased by 
13% since 2006, and the Centers for Disease Control and Prevention (CDC) 
estimates that there were 13.45 infections per 100,000 people in 2014 (CDC, 
2015). 
1.1 Human Illness 
 Infection in humans that is caused by Campylobacter spp. is known as 
campylobacteriosis, and it is characterized by an acute inflammatory lesion, 
primarily originating in the jejunum and ileum. C. jejuni is the primary cause of 
laboratory-confirmed infections, and C. coli is the second most commonly 
isolated species (CDC, 2015). Other laboratory-confirmed species that cause 
campylobacteriosis in the US include C. lari, C. upsaliensis, C. fetus, C. 
hyointestinalis, C. sputorum, C. helveticus, C. gracilis, C. muscosalis, and C. 
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showae (CDC, 2014; CDC, 2015). The infective dose may be as low as 500 cells 
(Black et al., 1988; Robinson, 1981). After an average incubation period of 3.2 
days, Campylobacter spp. infection generally elicits cramping pains followed by 
diarrhea, nausea, and continued abdominal pain. Symptoms are usually acute and 
begin to resolve after about 3 to 4 days; however, Campylobacter spp. may be 
shed in patients’ feces for several weeks. 
While infection is usually self-limiting, antibiotics may be prescribed. 
When necessary, the antibiotics of choice are macrolides, such as erythromycin 
(Blaser and Engberg, 2008). Until recently, fluoroquinolones, such as 
ciprofloxacin, have also been used as an alternative; however, the most recent 
national survey of antimicrobial resistance in the US identified resistance to 
ciprofloxacin in 22% of human C. jejuni isolates (CDC NARMS, 2015). 
Alternative antibiotics used to treat campylobacteriosis include tetracycline, 
doxycycline and chloramphenicol. 
Although gastrointestinal illness caused by Campylobacter spp. may 
resolve with or without antimicrobial intervention, several post-infection sequelae 
can develop weeks after the initial onset of infection. Campylobacter spp. have 
been identified as the source for approximately 20-50% of cases of Guillain-Barré 
syndrome, a peripheral neuropathy caused by molecular mimicry (Jacobs et al., 
2008). Lipooligosaccharides on the surface of Campylobacter cells resemble 
human neuronal gangliosides, leading to an autoimmune response against the 
nerves. Reactive arthritis has also been identified as a post-infection sequela, with 
incidence rates estimated to be between 1% and 5% of individuals previously 
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infected by Campylobacter spp. (Pope et al., 2007). Reactive arthritis may 
develop within 4 weeks of gastrointestinal illness caused by Campylobacter spp., 
as well as by other pathogens such as Salmonella and Shigella.  
1.2 Metabolism and Pathogenesis 
Campylobacter is a microaerophilic organism that requires 5-10% oxygen, 
and its ideal growth temperature is 30-37C. Several species, such as C. 
hyointestinalis, also require hydrogen for growth (Han et al., 1991). Thermophilic 
species, such as C. jejuni, will not grow below 30C, and they thrive at 42C. 
Campylobacter spp. cannot ferment or oxidize carbohydrate due to a lack of both 
6-phosphofructokinase and an active phospheoenolpyruvate-dependent 
phosphotransferase system (Velayudhan and Kelly, 2002). Rather, Campylobacter 
spp. obtain carbon from the oxidation of amino acids and tricarboxylic acids. 
Campylobacter spp. are very sensitive to many environmental conditions, such as 
drying or freezing (Cox et al., 2001). Campylobacter spp. require an elevated 
water activity level (0.987 to 0.997) and cannot withstand temperature 
fluctuations (Silva et al., 2011). During periods of stress or aging, Campylobacter 
spp. may become coccoid (Ng et al., 1985). In the laboratory setting, 
Campylobacter spp. must be provided a suitable atmospheric environment with 
appropriate sources of nutrients. For instance, Campylobacter spp. must be grown 
in a microaerophilic environment of 5% oxygen. Several less common, emerging 
species, such as C. hyointestinalis and C. sputorum, require hydrogen enrichment 
as well. Furthermore, an elevated incubation temperature of 42C will 
preferentially select for the more common thermophilic species, C. jejuni, C. coli 
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and C. lari, while less thermotolerant species, such as C. fetus, may fail to grow. 
Additionally, antimicrobial supplementation, which is commonly added to 
isolation media to inhibit competition of other enteric flora, may also inhibit the 
growth of Campylobacter spp. that are not resistant to cefoperazone, including C. 
concisus. Therefore, Campylobacter spp. are best suited for the gastrointestinal 
environment of warm-blooded animals, and isolation in the laboratory setting is 
dependent upon the specific materials and methods that are used. 
The pathogenesis of Campylobacter spp. is not as well-defined as other 
foodborne pathogens. However, some details are known about the colonization 
and invasion mechanisms and the varied pathogenicity in different host species. In 
the chicken gut, Campylobacter spp. primarily colonize the deep crypts of the 
cecum at up to 1010 colony-forming units per gram (Young et al., 2007). In 
bovine, Campylobacter spp. preferentially colonize the small and large intestine 
and are absent from the rumen (Inglis et al., 2005; Krueger et al., 2008), and 
Campylobacter spp. colonize the small intestine in humans.  
Several virulence factors have been identified as important for 
Campylobacter spp. survival and colonization. Motility via one or two polar 
flagella is vital to colonization of intestinal cells (Hermans et al., 2011). The 
corkscrew motion first allows penetration of the gut mucus layer. The flagella 
also act as a type III secretion system or flagellar export system which injects 
effector proteins, or Campylobacter invasion antigens (Cia), into the enterocyte 
(Konkel et al., 2004). The outer membrane protein, CadF, also binds to 
fibronectin on the basolateral epithelial cells of the gut to facilitate adhesion and 
5 
 
invasion (Konkel et al., 2001; Muller et al., 2006). Campylobacter spp. cells 
secrete cytolethal distending toxin (CDT), which cause cell cycle arrest and the 
eventual cell death of enterocytes (Young et al., 2007). The toxin is composed of 
subunits CdtA and CdtC, as well as the active subunit, CdtB. In the nucleus, CdtB 
exhibits a DNase-like activity. Death of enterocyte cells is also due to cytoskeletal 
rearrangements which inevitably lead to a loss of cell function and compromised 
barrier. 
1.3 Foodborne Illness 
1.3.1 Foodborne Outbreaks. 
In the US, foodborne illnesses are actively monitored by the CDC’s 
Foodborne Diseases Active Surveillance Network (FoodNet). According to 
FoodNet and the CDC, Campylobacter spp. infections have increased by 13% 
since 2006, leading to about 1.3 million cases and 120 deaths each year (Crim et 
al., 2015). Most sporadic illnesses are due to contaminated poultry; however, 
outbreaks have frequently been attributed to dairy products (Taylor et al., 2013; 
CDC, 2014). Between 1978 and 1986, 57.8% of foodborne outbreaks were linked 
to raw milk (Tauxe, 1992). The single most identified source of foodborne 
Campylobacter spp. outbreaks between 1997 and 2008 was due to the 
consumption of raw dairy products (28.0%, Taylor et al., 2013). Langer (2012) 
and Mungai (2015) also analyzed milk-related outbreak data from 1993 to 2012 
and found that the majority of foodborne outbreaks associated with raw milk were 
due to Campylobacter spp. Outbreaks caused by raw milk or contaminated water 
have been shown to have bimodal distribution, with more outbreaks observed in 
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May and October, possibly due to seasonal shedding of Campylobacter spp. in the 
feces of dairy cattle (Tauxe, 1992).  
1.3.2 Prevalence in Animals. 
Campylobacter spp. are considered to be commensal organisms of many 
wild animals as well as food animals, including poultry, cattle, sheep, and swine 
species. C. jejuni is the primary species found in poultry and cattle while C. coli is 
the most common Campylobacter spp. in swine (Manser and Dalziel, 1985). 
Other bovine-associated species include C. hyointestinalis, C. fetus subsp. fetus, 
and C. lanianae. Although most notably present in poultry intended for human 
consumption, such as chickens and turkeys, Campylobacter spp. have also been 
detected in wild birds, including migrating birds, which may be a source of 
transmission to farms (Sanad et al., 2013; Keller and Shriver, 2014; Ryu et al., 
2014).  
Previous surveys have found Campylobacter spp. to be present on most 
US dairy farms (USDA APHIS, 2011). Young calves excrete Campylobacter cells 
in high number from underdeveloped gastrointestinal systems while adults may 
shed intermittently throughout their lives (Nielson, 2002; Stanley and Jones, 
2003). Dairy cattle feces may yield between 2.1- 2.8 log10 (most probable number, 
MPN) per gram (Stanley et al., 1998; Nielson, 2002). Generally, Campylobacter 
spp. are non-pathogenic commensals of the bovine intestines, with several notable 
exceptions. Although uncommon, Campylobacter spp. have occasionally been 
implicated in cases of mastitis (Hutchinson et al., 1985; Morgan et al., 1985; Orr 
et al., 1995; Bianchini et al., 2014). More recently, a highly pathogenic, 
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tetracycline-resistant C. jejuni strain, clone SA, has been identified as the cause of 
ruminant abortions (Sahin et al., 2012). Campylobacter fetus subsp. fetus also 
may cause abortions in cattle. 
1.5 Milk and Pasteurization 
Milk is a common beverage consumed by more than 6 billion people 
worldwide (Visioli and Strata, 2014). In the US, milk produced by dairy cows is 
the most accessible type of animal milk, with approximately 206,046,000 lbs of 
dairy milk produced in 2014 (USDA ERS, 2015). In addition to Campylobacter 
spp., unpasteurized, raw milk can harbor many other human pathogens, including 
gram-negative bacteria such as Salmonella spp., Shiga toxin-producing 
Escherichia coli, and Yersinia spp., and gram-positive bacteria, such as Listeria 
spp. and Staphylococcus spp. (Karns et al., 2007; Latorre et al., 2011; Van Kessel 
et al., 2011). These pathogens are known to cause mild to severe gastrointestinal 
illness with occasional severe sequelae and potentially death. Several surveys 
determined that the prevalence of common gastrointestinal pathogens in bulk tank 
milk (BTM) ranges from 0.2% to 32.1% (Doyle and Roman, 1982; Lovett et al. 
1983; McManus and Lanier, 1987; Rohrbach et al., 1992; Jayarao and Henning, 
2001; Jayarao et al., 2006; Van Kessel et al., 2008; Latorre et al., 2011; Van 
Kessel et al., 2011). The bulk tank is the final collection point at which milk is 
combined and stored from multiple cows; therefore, sampling BTM yields a farm 
prevalence pooled from the animals on the farm. Most BTM contamination is the 
result of fecal contamination, poor equipment hygiene or human handling. Risk 
factors for BTM contamination may include animal hygiene, the age and cleaning 
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frequency of milking equipment, pre-and post-udder treatment and milk storage 
(Cerva et al., 2014). Mastitis or asymptomatic shedding occasionally may also be 
sources of pathogens in BTM. Human pathogenic organisms that also cause 
mastitis include Staphylococcus aureus, E. coli, Streptococcus agalactiae, S. 
dysgalactiae, S. uberis, and occasionally, Salmonella, Listeria monocytogenes, 
Mycobacterium bovis, Mycobacterium tuberculosis, and C. jejuni (Adams, 2008).  
Several regional surveys have specifically determined the prevalence of 
Campylobacter spp. in BTM. Surveys of dairy farms in Minnesota/South Dakota 
and Pennsylvania isolated Campylobacter spp. from 9.2% and 2.0% of BTM 
samples, respectively (Jayarao and Henning, 2001; Jayarao et al., 2006). Previous 
work with dairy-associated pathogens has also revealed the value of milk filter 
sampling as a more sensitive method of detecting of bacterial pathogens than 
BTM sampling alone (Van Kessel et al., 2008; Latorre et al., 2011; Van Kessel et 
al., 2011). The purpose of the milk filter is to remove large debris, such as 
bedding or feces, from the milk prior to storage in the bulk tank. With a common 
pore size of between 100 and 250 m, the filter is not designed to remove 
bacterial pathogens; however, bacterial cells may concentrate on the filter along 
with the debris. For example, a multi-state survey of 128 organic and 
conventional farms in the Michigan, Minnesota, New York, and Wisconsin 
obtained eleven Campylobacter spp. isolates from milk filters while three isolates 
were obtained from matching BTM samples (Halbert et al., 2006).  
Although dairy operations employ several strategies to reduce bacterial 
contamination in milk, these strategies are not 100% effective. Pasteurization was 
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introduced in the early 20th century as a method of combating diphtheria and 
typhoid fever. Low temperature-long time (LTLT) pasteurization involves heating 
at 63°C for 30 minutes, which is sufficient for killing M. tuberculosis and 
Coxiella burnetti, two heat-resistant non-spore-forming pathogens (Jay et al., 
2005). The more commonly utilized high temperature-short time (HTST) method 
involves heating to 72°C for 15 seconds. Ultra-high temperature (UHT) 
pasteurization requires heating for 135-140°C for at least 1 second. Pasteurization 
is also commonly coupled with homogenization, which breaks down fat globules 
in the milk. 
Although pasteurization greatly reduces the risk of foodborne illness, raw 
milk advocates have promoted potential health benefits and superior quality of 
unpasteurized, raw milk. Approximately 0.5 to 3.5% of the US population is 
estimated to drink raw milk (Lejeune and Rajala-Schultz, 2009). Proponents of 
drinking raw milk cite reductions in lactose intolerance and in the development of 
allergies as well as an improvement in taste and protein content (Davis et al., 
2014). Current research does not support the claim that raw milk consumption 
may reduce lactose intolerance. While several studies have observed a connection 
between raw milk and the prevention of allergies, authors of these studies still 
caution against consuming raw milk, citing the risk of illness due to zoonotic 
pathogens. Safer alternatives with a reduced risk of illness that also maintain 
many qualities of raw milk include vat pasteurization and non-homogenized milk. 
Additionally, many of the nutrients found in raw milk can be acquired from much 
safer food sources in a well-balanced diet. Due to the clear risk of foodborne 
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illness and lack of scientific evidence supporting beneficial claims, several major 
organizations, including the American Academy of Pediatrics and the National 
Mastitis Council, have issued position statements advising against the 
consumption of raw milk. 
Although alternatives exist and the transport of raw milk between states 
has been banned by the Food and Drug Administration (FDA) since 1987 (21 
C.F.R. § 1240.61) due to health concerns, some form of raw milk sales is 
permitted within 42 states (NCSL, 2015). Because intrastate sales are regulated by 
the individual states, several legal distribution methods exist. In the majority of 
states where it is legal, raw milk may be sold to consumers in retail stores, 
farmers’ markets or on the farm. Other states, such as Ohio and Indiana, permit 
herd or cow shares, in which the consumer shares ownership of the cow or herd. 
In Arkansas, Kentucky and Mississippi, raw cows’ milk sales are illegal; 
however, raw goats’ milk may be sold. With the exception of Michigan, all US 
states permit raw milk sales for animal consumption, which is regulated under 
commercial feed licensing laws. The regulations imposed by the FDA that require 
pasteurization of milk sold between states also set forth guidelines for the 
processing of cheese made from raw milk. The sale of hard cheese made from raw 
milk is permitted provided that it has been processed for at least 60 days. 
Although outbreaks have been attributed to the consumption of cheese made from 
raw milk, they are far fewer than those attributed to the consumption of raw milk 
itself. The extended processing time of cheese results in a dry, acidic environment 
which generally inhibits the growth of pathogenic bacteria (Taylor et al., 2013). 
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Therefore, consumption of raw milk is the primary source of foodborne illness 
attributed to dairy products. 
1.6 Antimicrobial Resistance 
 Due to increasing concern regarding the resistance of foodborne pathogens 
to antimicrobials used in human medicine, the CDC, along with the FDA, USDA 
and state and local public health departments, established an antimicrobial 
resistance monitoring system in 1996. The collaborative National Antimicrobial 
Resistance Monitoring System (NARMS) tracks antimicrobial resistance in 
enteric bacteria associated with human illness, food production animals and retail 
meats. Resistance is monitored in two pathogenic species, Salmonella spp. and 
Campylobacter spp., as well as two indicator species, E. coli and Enterococcus 
spp. Approximately 80% of Salmonella isolates were susceptible to all 
antimicrobials tested in 2012 and 2013 (CDC NARMS, 2014). Resistance to 
antimicrobials was noted most frequently in turkey isolates while cattle isolates 
were least frequently resistant. Similarly, resistance to at least one antimicrobial 
was more common in turkey E. coli isolates (~80%) and least common in cattle E. 
coli isolates (~20%). The majority of Enterococcus spp. isolates (90%) were 
resistant to at least one antimicrobial, with poultry isolates more frequently resistant 
than either cattle or swine. In 2012 and 2013, less than 3% of C. jejuni isolates from 
poultry and cattle were resistant to erythromycin, the drug of choice to treat 
campylobacteriosis in humans. Only 0.4% of dairy isolates were resistant to 
erythromycin. In comparison, 8.4% of dairy isolates were resistant to ciprofloxacin, 
an alternative campylobacteriosis treatment. 
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 The NARMS program specifically monitors the resistance of zoonotic 
pathogens to clinically important antimicrobials, including fluoroquinolones, 
cephalosporins and macrolides. In 2013, 3% of nontyphoidal Salmonella isolates 
from humans were resistant to nalidixic acid, a precursor to the fluoroquinolone, 
ciprofloxacin (CDC NARMS, 2015). Additionally, 3% of Salmonella human 
isolates were resistant to ceftriaxone, a third-generation cephalosporin. Resistance 
to ciprofloxacin was detected in 22% of C. jejuni human isolates while resistance 
to each of two macrolides, erythromycin and azithromycin, was detected in 2% of 
isolates. 
While NARMS and FoodNet monitor zoonotic pathogens in order to 
protect human health, the National Animal Health Monitoring System (NAHMS), 
which is coordinated by the USDA, monitors the health, management and 
productivity of domestic livestock in the US. The dairy industry has previously 
been surveyed by the NAHMS program in 1992, 1996, 2002, and 2007. During 
the NAHMS Dairy 2002 and 2007 studies, 49.5% and 36.6% of C. jejuni isolates 
were pansusceptible, respectively (Englen et al., 2007; USDA APHIS, 2011). In 
2002, 46.9% of isolates were resistant to a single antimicrobial while 61.2% were 
resistant in 2007. Multidrug resistance was detected in 3.6% and 2.2% of isolates 
in 2002 and 2007. Fewer than 5% of isolates were resistance to azithromycin, 
ciprofloxacin, chloramphenicol, clindamycin, erythromycin, gentamicin, or 
nalidixic acid; however, 47.4% and 62.9% of isolates in 2002 and 2007 were 
resistant to tetracycline. Resistance to ciprofloxacin and erythromycin is 
particularly concerning due to their use in the treatment of human 
campylobacteriosis. Resistance to tetracycline is not unexpected due to its 
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common use in calf milk replacers and foot baths as well as for therapeutic 
purposes (Zwald et al., 2004; Sato et al., 2004; Halbert et al., 2006; USDA 
APHIS, 2011). Recently, Sahin et al. (2012) identified a highly pathogenic 
tetracycline-resistance strain of C. jejuni in ruminant reservoirs that is responsible 
for sheep and cattle abortions as well as human illness. Other surveys of fecal, 
milk and milk filter isolates in the US have also identified moderate resistance to 
lincomycin, kanamycin and sulfamethoxazole (Harvey et al., 2004; Halbert et al., 
2006). Therefore, Campylobacter spp. isolated from dairy cows may also 
represent a reservoir for antimicrobial resistance. 
1.7 Goals and Objectives 
 
The goal of this research project was to assess the prevalence of the zoonotic 
pathogen, Campylobacter, in bulk tank milk and milk filters from US dairy 
operations. The following objectives were set in this study: 
 To determine the prevalence and antimicrobial resistance of 
Campylobacter spp. isolated from US dairy operations. 
 To identify Campylobacter species via multiplex PCR and to characterize 





Chapter 2: Campylobacter spp. in bulk tank milk and milk 
filters from US dairy farms 
 
2.1 Abstract 
Campylobacter is frequently isolated from dairy cows as commensal 
organisms. While sporadic Campylobacter infections in humans are generally 
attributed to poultry, outbreaks (defined as 2 or more affected people) are 
commonly associated with dairy products, particularly unpasteurized or raw milk. 
Bulk tank milk (BTM) samples and milk filters from US dairy operations were 
collected during the National Animal Health Monitoring System’s Dairy 2014 
study and analyzed by real-time PCR and traditional culture techniques for the 
presence of thermophilic Campylobacter species. Campylobacter spp. were 
detected in samples from 34.3% of dairy operations and isolated from 17.8% of 
operations. The majority (91.8%) of isolates were identified as C. jejuni, while C. 
lari and C. coli were also isolated. Resistance to tetracycline was detected in 
68.4% of C. jejuni isolates while resistance to ciprofloxacin and nalidixic acid 
was detected 13.2% of isolates. Based on analysis of pulsed-field gel 
electrophoresis patterns, dairy-associated C. jejuni are geographically diverse. 
Several isolates from multiple states were identified as a tetracycline-resistant 
strain known for its virulence in ruminants and as a source of human infection. 
These results from the first national survey of BTM and milk filters suggest that 
BTM can commonly be contaminated with pathogenic Campylobacter spp. and 





Campylobacter spp. are microaerophilic, spiral-shaped gram-negative 
bacteria that are a leading cause of bacterial diarrhea in the US and account for at 
least 1 million cases each year (CDC, 2015). Campylobacteriosis is usually self-
limiting, with symptoms such as mild diarrhea and cramping; however, severe 
cases may require antibiotics. Post-infection sequelae, such as Guillain-Barré 
syndrome, may cause life-long neurological problems. According to the Centers 
for Disease Control and Prevention (CDC), Campylobacter spp. infections in 
humans have increased by 13% from 2006 to 2014 (CDC, 2015). C. jejuni is the 
most common cause of campylobacteriosis; however, other thermophilic species, 
such as C. coli and C. lari, as well as emerging species, such as C. fetus, have also 
been known to cause illness (CDC, 2015; Taylor et al., 2013). 
Although sporadic Campylobacter spp. infections are commonly 
associated with poultry, Campylobacter spp. outbreaks have also been attributed 
to the consumption of other foods, particularly unpasteurized or raw milk. Raw 
milk represents a small percent of total milk consumed in the US; however, 
increasing interest in the potential health benefits, due to not heating the milk, 
represents a growing risk for campylobacteriosis (Lejeune and Rajala-Schultz, 
2009). Overall, the incidence of bacterial outbreaks involving raw milk has been 
estimated to be over 150 times greater than the incidence involving pasteurized 
milk (Langer et al., 2012). Based on a review of CDC data from 1997 to 2008, 
28% of foodborne Campylobacter spp. outbreaks were due to the consumption of 
contaminated raw milk products, which represented the largest single identified 
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source of campylobacteriosis (Taylor et al., 2013). Langer (2012) and Mungai 
(2015) analyzed milk-related outbreak data from 1993 to 2012 and found that the 
majority of foodborne outbreaks associated with unpasteurized milk were due to 
Campylobacter spp. contamination. Dairy products, particularly unpasteurized 
milk, are an important cause of Campylobacter spp. infection. 
Campylobacter spp. can colonize and be shed by otherwise healthy 
animals, including birds and mammals (Manser and Dalziel, 1985; Wesley et al., 
2000; Nielson, 2002; Miller, 2005). Although Campylobacter spp. can been 
excreted in the milk of infected cows, this is an uncommon occurrence 
(Hutchinson et al., 1985; Morgan et al., 1985; Orr et al., 1995; Bianchini et al., 
2014), and the presence of Campylobacter spp. in bulk tank milk (BTM) is 
usually due to fecal contamination from asymptomatic animals (Oliver et al., 
2005). National and regional surveys have consistently identified Campylobacter 
spp. on US dairy farms, particularly in fecal samples. As part of the USDA-
APHIS National Animal Health Monitoring System (NAHMS) Dairy studies in 
1996, 2002 and 2007, Campylobacter was identified in the feces of cows from 90-
100% of tested operations, and the most commonly isolated species was C. jejuni. 
(USDA APHIS, 2011). Regional and multi-state surveys have also identified 
Campylobacter spp. in BTM on US dairy farms. Surveys of farms between 1982 
and 1992 isolated Campylobacter from 0.4% to 12.3% of BTM samples (Doyle 
and Roman, 1982; Lovett et al., 1983; McManus and Lanier, 1987; Rohrbach et 
al., 1992). These studies collectively surveyed farms in Kentucky, Ohio, 
Tennessee, Indiana, Illinois, Michigan, Wisconsin, and Virginia. More recently, 
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Jayarao isolated Campylobacter spp. from 9.2% of BTM samples from farms in 
Minnesota and South Dakota (Jayarao et al., 2001) and from 2.0% of BTM from 
farms in Pennsylvania (Jayarao et al., 2006). Therefore, Campylobacter spp. can 
clearly contaminate the BTM, despite farm management practices. 
An additional concern for Campylobacter spp. as a foodborne pathogen is 
the potential for antimicrobial resistance. In the NAHMS Dairy Studies in 2002 
and 2007, C. jejuni isolates were tested for resistance to a panel of 10 
antimicrobials. Resistance to tetracycline was detected in 62.4% of C. jejuni 
isolates, compared to 47.5% in the 2002 study (USDA APHIS, 2011; Englen et 
al., 2007). Resistance to any of the 9 remaining antimicrobials ranged from 0% 
(susceptible) to 4.0%. Sahin et al. (2012) identified a highly pathogenic, 
tetracycline-resistant C. jejuni strain that was isolated from dairy farm 
environments. This strain, clone SA, has been implicated in ruminant abortions 
and has been isolated from human outbreaks attributed to raw milk as well as 
from raw milk and ruminant fecal samples. Other large dairy surveys have also 
reported Campylobacter spp. isolates with moderate resistance to multiple 
antibiotics, including kanamycin, lincomycin and sulfamethoxazole (Harvey et 
al., 2004; Halbert et al., 2006). 
Although the interstate transport of raw milk has been banned by the FDA 
since 1987, intrastate sale is regulated by individual states. Currently, some form 
of raw milk distribution is permitted in 42 states (NCSL 2015). Raw milk is also 
commonly consumed by farm families and employees (Shiferaw et al., 2000; 
Hegarty et al., 2002; Jayarao et al., 2006). Despite detection in both feces and 
18 
 
BTM from US dairy farms, no national surveys have been conducted on the 
prevalence of Campylobacter spp. in raw milk. Therefore, the objective of this 
study was to determine the overall prevalence of Campylobacter spp. in BTM and 




2.3 Materials and Methods 
2.3.1 Samples.  
Samples were collected as part of the NAHMS Dairy 2014 study. 
Operations were chosen based upon data from the USDA’s National Agricultural 
Statistics Service, which selected operations based on herd size from each of the 
17 top dairy states (California, Idaho, Indiana, Iowa, Kentucky, Michigan, 
Minnesota, Missouri, New Mexico, New York, Ohio, Pennsylvania, Texas, 
Vermont, Virginia, Washington, and Wisconsin) (Table 1). These states 
represented 80% of dairy herds and 80% of dairy cows in the US. The survey 
design was a stratified random sample with unequal selection probabilities in 
order to ensure the inclusion of large dairy operations. 
Those producers (n=3500) reporting one or more milk cows in their 
inventory on 1 January 2014 were included in Phase I of the NAHMS Dairy 2014 
study. In Phase I, National Agricultural Statistics Service enumerators 
administered a general management questionnaire to participating producers 
(n=1261). In Phase II, federal and state veterinary medicals officers or animal 
health technicians administered a veterinary questionnaire to operations (n=265) 
with 30 or more milk cows on 1 January 2014 that had participated in Phase I and 
agreed to continue participating in the study. From March 2014 to June 2014, 
trained staff aseptically collected BTM (50-100 mL) and milk filters from 
participating operations (n=234). The samples were shipped overnight on ice to 
the USDA, Agricultural Research Service in Beltsville, MD. Collected samples 
represented one milking cycle of the whole milking herd. 
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2.3.2 Bacteriological methods.  
For enrichment of Campylobacter spp. from BTM, multiple tubes of milk 
from an operation were first combined and mixed, then 25 mL was centrifuged at 
20,000  g for 35 min. The supernatant was discarded, and the pellet was 
resuspended in 45 mL Bolton Broth (Oxoid, England) with 5% Laked Horse 
Blood (Lampire, Pipersville, PA) and a Campylobacter selective supplement that 
contained cefoperazone, cycloheximide, trimethoprim, and vancomycin (Dalynn, 
Canada). For enrichment of Campylobacter spp. from milk filters, the filters were 
cut into small pieces, placed in filtered stomacher bags, and 1% buffered peptone 
water (1:1, wt/wt) was added. The bags were pummeled in an automatic bag 
mixer for 2 min, repositioned and then pummeled for an additional 2 min. Five 
mL of filtrate was added to 40 mL Bolton Broth with 5% Laked Horse Blood and 
a selective supplement that contained cefoperazone, cycloheximide, trimethoprim, 
and vancomycin. 
 For all samples, enrichment tubes were incubated at 37°C for 48 h in a 
10% CO2 incubator with loosened caps. After incubation, 2 mL of enrichment 
broth were centrifuged (12,000  g). The supernatants were discarded, and the 
bacterial pellets were suspended in 0.5 mL of 1X freezer medium (Schleif and 
Wensink 1981) and stored at -80°C. Additionally, 1.5 mL of enrichment broth 
was centrifuged (12,000  g), and nucleic acids were extracted from the bacterial 
pellets using 200 L of a commercially prepared extraction medium (mericon 
DNA Bacteria Kit Fast Lysis Buffer, Qiagen, Germany).  
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After incubation, 30 L of enrichment broth was also streaked onto 
Campy Blood-Free Selective Medium (Neogen, Lansing, MI) which was 
supplemented with cefoperazone (Neogen, Lansing, MI) and incubated at 42°C 
for 48 h in a microaerophilic environment (10% CO2, 5% O2, 85% N2) using an 
Anoxomat canister system (Mart Microbiology, The Netherlands). Two to five 
suspected Campylobacter spp. colonies were transferred from each plate to a 
panel of plates that included Campy Blood-Free Selective Medium, Columbia 
Agar with 5% Sheep Blood (BD, Sparks, MD), Brilliance CampyCount (Remel, 
Lenexa, KS), C. jejuni/C. coli Chromogenic Plating Medium (R&F Laboratories, 
Downers Grove, IL), and Mueller Hinton (Neogen, Lansing, MI) agar plates. 
DNA was extracted from one unique isolate from each sample using an InstaGene 
Matrix suspension (Bio-Rad, Hercules, CA) following the manufacturer’s 
protocol. Biomass from isolates was preserved in 500 L of a freezer medium 
consisting of 80% Bolton Broth, 15% glycerol and 5% Laked Horse Blood and 
stored at -80°C. 
2.3.3 Real-time PCR.  
The DNA preparations that were extracted from enrichments were 
analyzed by real-time PCR for the presence of C. jejuni, C. coli and C. lari using 
a commercial kit (mericon Campylobacter triple kit, Qiagen, Germany) following 
the manufacturer’s directions. Presumptive Campylobacter spp. isolates were also 
confirmed as such by a commercial real-time PCR kit. Reactions were run on a 
Stratagene Mx3005P qPCR system (Stratagene, La Jolla, CA) following the kit 
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manufacturer’s cycling protocol. Samples with a cycle threshold of less than 40 
cycles were considered positive. 
2.3.4 Species identification.  
Campylobacter species were determined by multiplex PCR of the isolate 
DNA preparations as described by Wang et al. (2002) with modifications. Each 
reaction mixture contained 240 μM deoxynucleoside triphosphate mixture 
(ThermoFisher, Lenexa, KS); 2.5 μL of 10X reaction buffer II; 4 mM MgCl2; 1.5 
U AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA); 0.6 μM C. 
jejuni and C. lari primers; 1 μM C. coli and C. fetus primers; 2 μM C. upsaliensis 
primers; 0.2 μM 23S rRNA primers; 1.0 μL of chromosomal DNA; and molecular 
biology grade water to a final volume of 26 μL. The reaction conditions were an 
initial incubation at 95°C for 10 min, followed by 30 cycles of 95°C for 30 s, 
59°C for 30 s, and 72°C for 30 s, with a final extension step of 72°C for 7 min. 
PCR reactions were run on a 1.5% agarose gel in 1X Tris-borate-EDTA buffer 
(Invitrogen, Grand Island, NY). C. jejuni NCTC 81116, C. coli ATCC 33559, C. 
lari 43675, C. fetus subsp. fetus ATCC 33246, and C. upsaliensis ATCC 43954 
were utilized as positive controls. 
2.3.5 Pulsed-field gel electrophoresis analysis. 
Molecular typing by pulsed-field gel electrophoresis (PFGE) was 
performed following the standardized PulseNet C. jejuni protocol (Ribot et al., 
2001) with a few modifications. Cultures were struck onto Columbia Blood Agar 
plates, and incubated at 42 for 48 h, and biomass from these plates was used for 
agarose plug preparation. The DNA in the plug slices was digested overnight with 
40 U SmaI. XbaI-digested S. enterica serotype Braenderup H9812 was the size 
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strain. Thiourea (50 μM) was added to both the gel and the electrophoresis buffer. 
Gels, composed of 1% SeaKem Gold agarose in Tris-borate-EDTA, were run on 
CHEF-DR II or CHEF-DR III systems for 18.5 h. The gels were stained with 
1μg/mL ethidium bromide and destained with 4 washings. Images of the 
restriction digest patterns were obtained using a ChemiDoc XRS gel 
documentation system (Bio-Rad, Hercules, CA). Bands were manually assigned 
and analyzed using BioNumerics software (Applied Maths, Austin, TX). 
Dendrograms were derived using the unweighted pair group method with 
arithmetic average cluster analysis with a band position tolerance of 1.0% and 
optimization of 0.5%. 
2.3.6 Antimicrobial susceptibility testing.  
Resistance to a panel of 9 commonly used antimicrobials (azithromycin, 
ciprofloxacin, erythromycin, gentamicin, tetracycline, florfenicol, nalidixic acid, 
telithromycin, and clindamycin) was assessed using an automated microdilution 
procedure (Sensititre, ThermoFisher, Lenexa, KS). Antimicrobial minimum 
inhibitory concentrations (MICs) were interpreted based upon the epidemiological 
cut-off values (ECOFFs) used by the National Antimicrobial Resistance 
Monitoring System (NARMS) (Table 2). C. jejuni ATCC 33560 was used as a 
susceptible quality control strain. 
2.4 Results 
A total of 234 BTM samples and 231 milk filter samples were received 
between March and June 2014 (Table 1). Paired samples of milk and filters were 
received from 231 dairy operations and 3 operations submitted only milk samples. 
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Field personnel were instructed to collect milk samples and all associated milk 
filters from a single milking for the herd. The number of filters collected from 
individual herds ranged from 1 to 20 filters. When necessary, filters from the 
same operation were divided into multiple enrichments; however, results from 
multiple filter samples from the same operation were combined for analysis. 
Overall, samples were received from 234 operations in 17 states.  
When DNA extracts from enrichment biomass was tested for the presence 
of thermophilic Campylobacter spp. (C. jejuni, C. coli, C. lari), samples with a 
real-time PCR cycle threshold of less than 40 cycles were considered positive. 
The cycle thresholds of positive samples ranged from 14.3 to 39.5. Based on real-
time PCR analysis, 27 milk samples and 69 filter samples were positive for the 
presence of C. jejuni, C. coli or C. lari, representing 11.5% and 29.5% of tested 
operations, respectively (Table 3). Cycle thresholds greater than 32 were obtained 
from 41 of the 96 PCR-positive samples. Overall, enrichments from 80 operations 
(34.2%) were positive for thermophilic Campylobacter species. Sixteen 
operations (6.8%) tested positive for Campylobacter spp. in both the BTM and 
filter samples. Campylobacter was detected in the filter sample alone for 53 
operations (22.6%) while it was detected in the BTM sample alone for 9 
operations (3.8%). Campylobacter was also detected in 2 BTM samples (0.9%) 
that were submitted without accompanying filter samples. 
Campylobacter spp. were isolated from the filter samples of 33 operations 
and from the BTM samples of 14 operations, representing a total of 43 operations 
(18.4%). Isolates were obtained from both the BTM and filter samples of 4 
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operations (1.7%). Campylobacter spp. were isolated from only the filter samples 
from 29 operations (12.4%) and from only the BTM samples from 9 operations 
(3.8%). Isolates were also obtained from one BTM sample (0.4% of operations) 
that did not have an accompanying filter sample. 
When 49 Campylobacter isolates were analyzed using multiplex PCR, 45 
isolates (91.8%) were identified as C. jejuni, 3 isolates were C. lari and 1 isolate 
was C. coli. Of these 49 isolates, one C. jejuni isolate and one C. lari isolate were 
obtained from a single filter sample (Pair 23). Seven isolates could not be 
resuscitated from preservation and one C. jejuni isolate repeatedly failed to grow 
on the microdilution plate used for susceptibility testing. The remaining 41 
Campylobacter spp. isolates were tested for resistance to 9 common antibiotics 
utilizing an automated microdilution procedure (Table 4). Both C. lari isolates 
were resistant to ciprofloxacin and nalidixic acid while the C. coli isolate was 
susceptible to all 9 antibiotics. Of the 38 C. jejuni isolates tested, 26 isolates 
(68.4%) were resistant to tetracycline. Five (13.2%) of these tetracycline-resistant 
C. jejuni isolates were also resistant to both ciprofloxacin and nalidixic acid. 
Twelve C. jejuni isolates (31.6%) were susceptible to each of the 9 antibiotics.  
In total, 42 Campylobacter isolates were analyzed by PFGE. This included 
the one C. jejuni isolate for which antimicrobial susceptibility could not be 
determined. The PFGE banding patterns of the SmaI digests of C. jejuni isolates 
were composed of 6 to 10 fragments (Figure 1). The C. coli isolate was composed 
of 7 fragments while the 2 C. lari isolates were composed of 4 and 7 fragments. 
When the banding patterns of all isolates were compared, the 2 C. lari and one C. 
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coli isolate were distinct, sharing less than 35% similarity with the C. jejuni 
isolates. While the 39 C. jejuni isolates clustered separately from C. lari and C. 
coli, significant diversity was observed within the species, and this diversity 
extended across geographical regions. C. jejuni isolates grouped into 4 clades, 
with each sharing at least 50% similarity between isolates within each clade. 
Eight isolate pairs and one group of 3 isolates were indistinguishable (100% 
similarity). Of these 9 groups, 4 represented isolates from the same state whereas 
5 were from differing, and generally non-neighboring, states. Three 
indistinguishable pairs represented isolates from BTM and milk filter pairs from 
the same operations. Antimicrobial resistant phenotypes were dispersed across 
clades. Of the 9 indistinguishable groups, 7 groups displayed identical 
antimicrobial resistance or susceptibility profiles. 
When the PFGE patterns of the Campylobacter isolates were compared 
with the CDC’s PulseNet database, 35 C. jejuni isolates and 1 C. coli isolate 
matched strains isolated from human outbreaks in 2015. The pulsetypes of seven 
these isolates matched C. jejuni outbreak pulsetypes of isolates from raw milk. 
Four isolates from 4 different states matched a highly-virulent C. jejuni strain 
noted for its role in ruminant abortions and resistance to tetracycline. Of the 36 
Campylobacter isolates, 26 matched pulsetypes in the database that were obtained 





Campylobacter spp. are a leading cause of human foodborne illness. 
While sporadic infections are typically associated with poultry, outbreaks have 
been attributed to milk and dairy products, with the majority of outbreaks 
attributed to unpasteurized or raw milk (Taylor et al., 2013; Mungai, 2015). 
Recurrent outbreaks of campylobacteriosis from raw milk sold by one 
Pennsylvania farm occurred in both 2012 and 2013, leading to illness in multiple 
states (CDC, 2013; Longenberger et al., 2013). Although far fewer, 
Campylobacter outbreaks have also been attributed to pasteurized milk, 
potentially due to post-pasteurization contamination (Taylor et al., 2013). 
Previous national surveys have determined that Campylobacter spp. can be 
detected on nearly all dairy farms, and multi-state surveys have also isolated 
Campylobacter spp. from BTM. (NAHMS, 2002; NAHMS, 2007; Halbert et al., 
2006) 
Campylobacter spp. were identified in about one-third of the BTM and 
filter samples collected from US dairy operations as part of the NAHMS 2014 
Dairy study. Thermophilic Campylobacter spp. (C. jejuni, C. lari, C. coli) were 
detected in samples collected from 34.2% of operations from 17 top dairy states in 
the US. This survey involved a single point-in-time sampling and therefore may 
underestimate the contamination. Previous research indicates that Campylobacter 
spp. may be shed seasonally in dairy animals, with peaks in the spring in 
Wisconsin and peaks in spring and fall in the United Kingdom (Stanley et al., 
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1998; Sato et al., 2004). Therefore, the prevalence of Campylobacter spp. in BTM 
could vary along with seasonal fluctuations in shedding.  
 
Campylobacter spp. isolates were obtained from approximately half of the 
samples that were identified as positive via PCR (18.4% vs 34.2%). 
Campylobacter spp. are challenging to culture in the laboratory and require a 
microaerophilic environment as well as supplementation with antibiotics to inhibit 
competition. Although Campylobacter spp. were not isolated from all samples in 
which detected, a prevalence of 18.4% via culture methods represents an increase 
from previous multi-state surveys, which isolated Campylobacter spp. from 
between 0.9% and 12.3% of BTM samples. (Doyle and Roman, 1982; Lovett et 
al., 1983; McManus and Lanier, 1987; Rohrbach et al., 1992). 
Campylobacter spp. were detected in the filter samples but not in the BTM 
samples from 53 operations (22.6%). Previous work with Campylobacter spp. and 
other dairy-associated pathogens has illustrated the value of milk filter sampling 
as a more sensitive method of detecting of bacterial pathogens than BTM 
sampling alone (Giacometti et al., 2012; Latorre et al., 2011; Leone et al., 2010; 
Serraino et al., 2013; Van Kessel et al., 2008; Van Kessel et al., 2011). A multi-
state survey of 128 organic and conventional farms in the Michigan, Minnesota, 
New York, and Wisconsin obtained 11 isolates from milk filters, but only 3 
isolates from BTM samples (Halbert et al., 2006). In comparison, surveys of BTM 
and filters in Italy, where raw milk is legally sold, detected Campylobacter spp. in 
22.2% to 63% of milk filter samples (Giacometti et al., 2012; Serraino et al., 
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2013; Leone et al., 2010) and 12% to 68% of BTM samples (Leone et al., 2010; 
Bianchini et al., 2014). 
Although most frequently identified in the milk filters, Campylobacter 
spp. were also isolated from the BTM from 9 operations while the filter samples 
from the same operation were negative. Detection in the BTM but not the filter 
may be due to the sensitivity of Campylobacter spp. to environmental conditions, 
such as drying or freezing (Cox et al., 2001). Campylobacter spp. require an 
elevated water activity level (0.987 to 0.997) and cannot withstand temperature 
fluctuations or increased oxygen concentrations (Silva et al., 2011). Filter samples 
were shipped overnight in reclosable bags; however, the condition of the filters 
upon arrival varied, potentially impacting the ability to recover Campylobacter 
spp. from the sample. Although producers and field staff received instructions on 
proper collection technique, some filters appeared dry or were shipped in unsealed 
bags. Other filter samples appeared to have been rinsed with water. Therefore, the 
sensitivity of the organism combined with the inconsistency in sample condition 
may have reduced the ability to obtain Campylobacter spp. isolates. 
C. jejuni is the most frequent Campylobacter species associated with dairy 
animals and their environment and with human illness (CDC, 2014) and was the 
predominant species isolated in this study. Of the 49 isolates obtained from BTM 
and milk filter samples, 45 were C. jejuni. One C. jejuni was isolated from a milk 
filter from which C. lari was also isolated. When the susceptibility of these 
isolates to a panel of common antimicrobials was tested, twelve C. jejuni isolates 
(31.6%) were susceptible to all 9 antimicrobials; however, 68.4% of C. jejuni 
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isolates were resistant to tetracycline (Table 4). Although BTM and milk filters 
were not tested for the presence of Campylobacter spp. in the previous NAHMS 
2007 study, 62.5% of C. jejuni isolates from fecal samples in 2007 were also 
resistant to tetracycline. Tetracycline and its derivatives are commonly used on 
dairy operations in milk replacers and foot baths; therefore, resistance in the dairy 
environment is not unexpected (NAHMS, 2007; Zwald et al., 2004). Five of the 
tetracycline-resistant isolates were also resistant to ciprofloxacin and nalidixic 
acid. Campylobacteriosis in humans, most frequently due to C. jejuni, is usually 
self-limiting; however, when antimicrobial intervention is deemed necessary, 
erythromycin is the drug of choice. Ciprofloxacin may also be used as an 
alternative; however, the most recent national monitoring survey of antimicrobial 
resistance in the US identified resistance to ciprofloxacin in 22% of human C. 
jejuni isolates and 8.5% of dairy fecal isolates (NARMS, 2013).  
C. coli is the second most common cause of human infection. One C. coli 
isolate from a milk filter was susceptible to all tested antimicrobials. While C. lari 
causes human illness infrequently, it is intrinsically resistant to quinolones 
(Skirrow and Benjamin, 1980; CDC, 2014). Resistance to the quinolones, 
ciprofloxacin and nalidixic acid, was observed in the 2 C. lari isolated from milk 
filter samples. 
 When the PFGE SmaI restriction digest patterns were compared, the 
diversity within C. jejuni isolates and their distinction from C. lari and C. coli 
were observed. In two large surveys of fecal samples from cows on US dairy 
farms, Harvey (2005) and Sanad (2011) similarly noted diversity in the digest 
31 
 
patterns of Campylobacter spp. isolated from multiple states. This diversity has 
been attributed to transmission of Campylobacter to dairy animals from migratory 
birds, wildlife, livestock, or humans. Additionally, Campylobacter spp. are 
naturally competent and also rapidly evolve, with mutations within the population 
occurring within the course of a week (Young et al., 2007; Wilson et al., 2009). 
When comparing the restriction digest patterns of isolates from the BTM and 
filters, several C. jejuni isolate groups were indistinguishable. Five of these 
indistinguishable groups were obtained from operations in different states while 
three indistinguishable groups of isolates represented BTM and milk filter pairs 
from the same operation. A fourth BTM-milk filter isolate pair (Pair 196) yielded 
two distinct PFGE patterns, illustrating the diversity of C. jejuni even at the farm 
level. This farm-level diversity could be due to the infection and shedding of 
different strains by multiple cows or, alternatively, the shedding of multiple 
strains by the same cow. Nielson (2002) similarly observed that individual 
animals could shed multiple serotypes. 
When restriction digest patterns were compared with antimicrobial 
resistance phenotypes, no consistent association was observed. Harvey (2005) 
similarly observed that antimicrobial resistance patterns differed within genotypes 
of isolates from three geographic regions (northeast, southwest, west) despite 
similar genotypic patterns throughout these regions. In this study, resistance to 
tetracycline was observed throughout the four C. jejuni clades and across 
geographic regions (Figure 1). In each of 2 pairs of indistinguishable C. jejuni 
isolates, one isolate was resistant to tetracycline while the second was 
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pansusceptible. Resistance to ciprofloxacin and nalidixic acid was observed in 
isolates from two separate C. jejuni clades. Therefore, C. jejuni isolates are 
geographically dispersed and have varying degrees of resistance between 
indistinguishable isolates and across both clades and geographic regions. 
The CDC collects PFGE patterns of pathogenic isolates from humans and 
other sources in the PulseNet database in order to detect foodborne outbreaks. 
When the PFGE patterns of the Campylobacter spp. isolates were compared with 
the PulseNet database, 35 of 39 C. jejuni isolates matched isolates from human 
outbreaks from 2015, of which 7 were isolated from raw milk. The PFGE pattern 
of 4 isolates matched a highly-virulent C. jejuni strain, known as clone SA (Sahin 
et al., 2012). Clone SA is associated with abortions in ruminants; however, the 
isolates from the 2015 PulseNet database were originally isolated from chickens. 
An additional 22 isolates matched isolates in the database that were obtained from 
poultry sources, such as chicken breasts, indicating that Campylobacter is not 
host-specific. 
Campylobacter spp. are not only present on most dairy farms in the US, 
but can also contaminate BTM. Campylobacter spp. were detected in the BTM 
and milk filters from one-third of US operations tested as part of the NAHMS 
Dairy 2014 study. Additionally, 68.4% of Campylobacter spp. isolates were 
resistant to at least one antimicrobial. Although Campylobacter spp. can be killed 
through proper pasteurization, there is a risk of foodborne illness for a segment of 




Chapter 3: Conclusion 
Campylobacter spp. are the primary cause of foodborne outbreaks 
attributed to raw milk and can be isolated from most US dairy environments. To 
date, no national study has determined the prevalence of Campylobacter spp. in 
unpasteurized, raw BTM on US dairy farms. The results of this study suggest that 
Campylobacter spp. are a common contaminant of BTM on US dairies and 
confirm the results of previous multi-state surveys of BTM. Although proper 
pasteurization can eliminate Campylobacter spp., there is clearly a risk of 
foodborne illness to consumers of unpasteurized, raw milk. Further analysis of 
data collected as part of this study may also compare Campylobacter prevalence 
to farm location, size and management practices in order to identify where 
improvements can be implemented to limit Campylobacter contamination in the 
BTM. A risk assessment comparing both the hazards and benefits of 
unpasteurized and pasteurized milk would also be valuable. Together, the 
prevalence, antimicrobial resistance and molecular typing results from this study 
will contribute to the evidence of Campylobacter spp. prevalence on US dairy 
farms. These results provide support to the positions of many major organizations, 
such as the National Mastitis Council and the American Academy of Pediatrics, 






Table 1. State of origin and summary of bulk tank milk samples and milk filter 




Sample counts (no.) 
State 
Milk Filter Pairs1 
Milk, 
no filters2 
CA 22 22 22 22 0 
CO 5 5 5 5 0 
ID 6 6 6 6 0 
IN 3 3 3 3 0 
IA 12 12 12 12 0 
KY 1 1 1 1 0 
MI 18 18 17 17 1 
MN 24 24 24 24 0 
MO 2 2 2 2 0 
NY 33 33 33 33 0 
OH 10 10 10 10 0 
PA 19 19 19 19 0 
TX 1 1 1 1 0 
VT 1 1 1 1 0 
VA 8 8 7 7 1 
WA 11 11 11 11 0 
WI 58 58 57 57 1 
Total 234 234 231 231 3 
1 Number of operations from which there was both a bulk tank milk sample and a 
filter sample. 
2 Number of operations from which milk samples were submitted but there was no 
corresponding filter sample from the same operation.  
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Azithromycin ≥ 0.5 ≥ 1 
Ciprofloxacin ≥ 1 ≥ 1 
Erythromycin ≥ 8 ≥ 16 
Tetracycline ≥ 2 ≥ 4 
Florfenicol ≥ 8 ≥ 8 
Nalidixic Acid ≥ 32 ≥ 32 
Telithromycin ≥ 8 ≥ 8 
Clindamycin ≥ 1 ≥ 2 
Gentamicin ≥ 4 ≥ 4 
1Based on The European Committee on Antimicrobial Susceptibility Testing 
2Minimum Inhibitory Concentrations (MICs)/ECOFFs, g/mL 
3No specific ECOFFs for C. lari  
36 
 
Table 3. Number and percent of US dairy farms that tested positive for 
Campylobacter spp. by PCR and culture in bulk tank milk and milk filters1 










Positive milk  27 11.5  14 6.0 
Positive filter  69 29.5  33 14.1 
Positive milk and positive filter 16 6.8  4 1.7 
Negative milk and positive filter 53 22.6  29 12.4 
Positive milk and negative filter 9 3.8  9 3.8 
Positive milk and no filter sample 2 0.9  1 0.4 




Table 4. Resistance and resistance profiles of Campylobacter spp. isolates (n=41) 
from bulk tank milk and milk filters from US dairies. 
   No. of 
isolates 
 




Tetracycline 26  68.4 
Ciprofloxacin 5  13.2 
Nalidixic Acid 5  13.2 
Pansusceptible2 12  31.6 
Resistance Profile 




5  13.2 
Pansusceptible1 12  31.6 
C. lari 
Resistance 
Ciprofloxacin 2  100.0 
Nalidixic Acid 2  100.0 
Resistance Profile 
Ciprofloxacin and  
Nalidixic Acid 
2  100.0 
C. coli  Pansusceptible1 1  100.0 
1Susceptible to azithromycin, ciprofloxacin, erythromycin, tetracycline, 





Figure 1. Dendrogram of SmaI-digested pulsed-field gel electrophoresis patterns.  
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